Back to Search
GREGORY BEATTY, MD
MD
Medical Oncology Physician
NPI: 1730242363Individual
Specialties, Licenses & Credentials
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
MD430283(PA)
Research & Publications (20)
Functional unresponsiveness and replicative senescence of myeloid leukemia antigen-specific CD8+ T cells after allogeneic stem cell transplantation.
PMID 19602548·Clin Cancer Res·2009
8-other
Telomerase as a universal tumor antigen for cancer vaccines.
PMID 18767939·Expert Rev Vaccines·2008
6-review
Bevacizumab and oxaliplatin-based chemotherapy in metastatic colorectal cancer.
PMID 18471041·Expert Rev Anticancer Ther·2008
6-review
Regulation of tumor growth by IFN-gamma in cancer immunotherapy.
PMID 11594457·Immunol Res·2001
6-review
IFN-gamma-dependent inhibition of tumor angiogenesis by tumor-infiltrating CD4+ T cells requires tumor responsiveness to IFN-gamma.
PMID 11160282·J Immunol·2001
7-preclinical
IFN-gamma can promote tumor evasion of the immune system in vivo by down-regulating cellular levels of an endogenous tumor antigen.
PMID 11067903·J Immunol·2000
7-preclinical
Quantification of insulin-mediated glucose disposal in HIV-infected individuals: comparison of patients treated and untreated with protease inhibitors.
PMID 12792353·J Acquir Immune Defic Syndr·2003
3-trial
Collapse of the CD27+ B-cell compartment associated with systemic plasmacytosis in patients with advanced melanoma and other cancers.
PMID 19549767·Clin Cancer Res·2009
8-other
Immunosurveillance of pancreatic adenocarcinoma: insights from genetically engineered mouse models of cancer.
PMID 19013709·Cancer Lett·2009
6-review
High dispersal potential has maintained long-term population stability in the North Atlantic copepod Calanus finmarchicus.
PMID 18812293·Proc Biol Sci·2009
7-preclinical
Effect of baseline viral susceptibility on response to darunavir/ritonavir versus control protease inhibitors in treatment-experienced HIV type 1-infected patients: POWER 1 and 2.
PMID 18844462·AIDS Res Hum Retroviruses·2008
3-trial
Telomerase-specific T-cell immunity in breast cancer: effect of vaccination on tumor immunosurveillance.
PMID 17974999·Cancer Res·2007
8-other
Interruption of enfuvirtide in HIV-1 infected adults with incomplete viral suppression on an enfuvirtide-based regimen.
PMID 17205477·J Infect Dis·2007
3-trial
Phase I clinical trial of costimulated, IL-4 polarized donor CD4+ T cells as augmentation of allogeneic hematopoietic cell transplantation.
PMID 17085308·Biol Blood Marrow Transplant·2006
3-trial
Rapid emergence of enfuvirtide resistance in HIV-1-infected patients: results of a clonal analysis.
PMID 16885776·J Acquir Immune Defic Syndr·2006
8-other
A randomized pilot study comparing combination therapy plus enfuvirtide versus a treatment interruption followed by combination therapy plus enfuvirtide.
PMID 16759047·Antivir Ther·2006
4-observational
Tumor sensitivity to IFN-gamma is required for successful antigen-specific immunotherapy of a transplantable mouse tumor model for HPV-transformed tumors.
PMID 15750832·Cancer Immunol Immunother·2005
7-preclinical
Methods for quantifying insulin resistance in human immunodeficiency virus-positive patients.
PMID 12870161·Metabolism·2003
8-other
Variable patterns of septal activation in patients with left bundle branch block and heart failure.
PMID 12693492·J Cardiovasc Electrophysiol·2003
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3400 CIVIC CENTER BOULEVARD
PHILADELPHIA, PA 19104 - Phone
- (215) 615-5858
Quick Facts
- NPI
- 1730242363
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile